Jan. 4, 2024

W. Kimryn Rathmell, MD, assumed the role of director of the National Cancer Institute (NCI) Dec. 18. NCI is one of the 27 institutes and centers of the National Institutes of Health (NIH). It is the federal government’s principal agency for cancer research and training, and the largest funder of cancer research in the world with a current fiscal year 2023 budget of $7.3 billion.

President Biden announced his intention to nominate Rathmell to succeed Monica Bertagnolli, MD, who was confirmed as the NIH director Nov. 9.

Rathmell comes to NCI from Vanderbilt University Medical Center, where she was the physician-in-chief and the chair of the department of medicine. Her past research focused on the underlying drivers of kidney cancers by using genetic, molecular and cell biology to develop robust approaches to improve patient outcomes. Rathmell is the second woman to hold the post.

The American College of Radiology® (ACR®) continues to encourage imaging as a priority in Dr. Rathmell’s role as NCI director and welcomes the opportunity for future collaborations.

For more information, contact Katie Grady, ACR Government Affairs Director.


Related ACR News

  • State Legislatures Are Active As May Begins

    The American College of Radiology® (ACR®) is providing this weekly update on state bills as many state legislatures look to the end of their legislative sessions in the month of May.

    Read more
  • ACR Attends April 2025 RUC Meeting

    The ACR® participated in the American Medical Association/Specialty Society RVS Update Committee (RUC) meeting where they heard an update on the AMA’s Physician Practice Information Survey.

    Read more
  • Senate Committee Hearing Covers Concerns Related to Biomedical Research

    The U.S. Senate Committee held a hearing to discuss the importance of U.S. biomedical research for the nation’s health and economy.

    Read more